The U.S. Supreme Court will consider Amgen's challenge to a securities lawsuit alleging the biotech company played down safety concerns about two drugs used to treat anemia.
WSJ.com: What's News US, Wall Street Journal
Mon, 06/11/2012 - 9:54am
The U.S. Supreme Court will consider Amgen's challenge to a securities lawsuit alleging the biotech company played down safety concerns about two drugs used to treat anemia.